Can You Transfer a Prescription to Another State (2026): A 50-State Breakdown
Need the exact statute?
Cited answers for all 50 states.
Can You Actually Transfer a Prescription to Another State?
The short answer is yes—with significant caveats depending on the drug schedule and which state you're in.
Federal law does not prohibit pharmacies from filling prescriptions written by out-of-state prescribers. The DEA clarified this explicitly in a June 2024 guidance document, stating that neither the Controlled Substances Act nor DEA regulations prevent a pharmacist from dispensing a controlled substance prescribed by a practitioner registered in a different state [1]. The prescriber must hold a valid DEA registration, and a legitimate prescriber-patient relationship must exist under 21 CFR 1306.04(a).
The complication is that state pharmacy boards set their own rules on top of the federal baseline. Some states accept out-of-state prescriptions for all drug schedules without issue. Others restrict which schedules can cross their borders, require additional verification steps, or limit fills to prescribers licensed in specific neighboring states.
For a deeper dive into prescribing authority variations, see our guide to NP Prescribing Authority by State.
How Federal Law Governs Prescription Transfers
Before looking at individual states, it helps to understand the federal framework that sets the floor for all transfer rules.
Non-Controlled Medications
There is no federal restriction on transferring non-controlled prescriptions between pharmacies in different states. A pharmacist at the receiving pharmacy contacts the transferring pharmacy, verifies the prescription details, and dispenses the medication. Chain pharmacies sharing a real-time database (CVS, Walgreens, Walmart) can access records across locations without a formal pharmacist-to-pharmacist transfer.
Schedule III–V Controlled Substances (Refills)
Under 21 CFR 1306.25, prescriptions for Schedule III, IV, and V controlled substances can be transferred one time for refill purposes between pharmacies [2]. The transfer must be communicated directly between two licensed pharmacists. Pharmacies sharing a real-time online database may transfer up to the maximum refills authorized by the prescriber.
Schedule II–V Controlled Substances (Initial Fill)
The DEA's final rule published July 27, 2023 (effective August 28, 2023) was a landmark change. It allows electronic prescriptions for Schedule II–V controlled substances to be transferred between DEA-registered retail pharmacies one time for initial filling, at the patient's request [3]. Key requirements:
- Both pharmacies must be DEA-registered retail pharmacies.
- The transfer must be communicated directly between two licensed pharmacists.
- The prescription must remain in electronic form and cannot be altered during transmission.
- State law must also permit the transfer—this is where the real complexity begins.
Paper prescriptions for Schedule II drugs cannot be transferred between pharmacies under federal law. If a pharmacy cannot fill a paper Schedule II prescription, the patient must return to the prescriber for a new prescription sent to a different pharmacy.
State-by-State Restrictions on Out-of-State Prescriptions
Here is where interstate prescription fills get complicated. The table below summarizes how selected high-population and high-restriction states handle out-of-state prescriptions, particularly controlled substances.
| State | Non-Controlled Rx | Sch III–V Transfer | Sch II Transfer (Electronic) | Notable Restrictions |
|---|---|---|---|---|
| California | Accepted | One-time, per federal rules | Permitted if state law criteria met | Strict verification required for out-of-state controlled Rx; CURES PDMP check mandatory [4] |
| Florida | Accepted | One-time, per federal rules | Permitted with documentation | Stricter documentation for Sch II; telehealth providers cannot prescribe Sch II via telehealth except in limited situations [5] |
| Massachusetts | Accepted | One-time, per federal rules | Sch II narcotics: contiguous states + Maine only | Sch II non-narcotics accepted from any state; Sch II narcotics only from VT, NH, NY, CT, RI, and ME [6] |
| New Jersey | Accepted | One-time, per federal rules | Sch II transfers prohibited | N.J.A.C. 13:39-7.8 explicitly prohibits transfer of Schedule II prescriptions between pharmacies [7] |
| New York | Accepted (e-Rx mandate) | One-time, per federal rules | Permitted electronically | All Rx must be electronic per I-STOP; out-of-state paper Rx complicates fills; PDMP check required for Sch II–IV [8] |
| Pennsylvania | Accepted | One-time, per federal rules | Sch II transfers prohibited | PA Pharmacy Act §4(a)(3.1)(ii) bars Sch II transfers; legislative change required to permit them [9] |
| Texas | Accepted with valid Rx | One-time, per federal rules | Permitted if legal requirements met | Out-of-state Rx accepted if valid doctor-patient relationship exists; Sch II from Canada/Mexico prohibited [10] |
| Arizona | Accepted | One-time, per federal rules | Permitted | Explicitly allows Sch II fills from out-of-state practitioners if Rx complies with AZ and federal law [11] |
| Michigan | Accepted | One-time, per federal rules | Permitted | MAPS PDMP check required; 7-day acute opioid limit applies |
| Illinois | Accepted | One-time, per federal rules | Permitted | ILPMP check required before initial Sch II opioid Rx |
States That Restrict Schedule II Transfers or Out-of-State Fills
Not all restrictions are equal. Here's a breakdown of the three most common types of state-level barriers.
1. Outright Schedule II Transfer Prohibitions
Pennsylvania and New Jersey both prohibit the transfer of Schedule II prescriptions between pharmacies. In Pennsylvania, this restriction is codified in the Pharmacy Act itself, meaning only a legislative amendment can change it [9]. New Jersey's administrative code is similarly explicit [7].
In these states, if a patient has a Schedule II electronic prescription sent to Pharmacy A and wants to move it to Pharmacy B, the prescriber must cancel the original and issue a new prescription directly to the second pharmacy.
2. Geographic Limitations on Schedule II Narcotics
Massachusetts takes a unique approach: it allows Schedule II non-narcotic prescriptions from any state, but restricts Schedule II narcotic prescriptions to those issued by providers licensed in states contiguous to Massachusetts (Vermont, New Hampshire, New York, Connecticut, Rhode Island) plus Maine [6]. Mail-order pharmacies in Massachusetts are exempt from this geographic limitation.
3. E-Prescribing Mandates That Create Friction
New York mandated electronic prescribing for all medications (controlled and non-controlled) effective March 27, 2016, under the I-STOP Act [8]. While out-of-state prescribers issuing prescriptions to be dispensed outside New York are exempt from the e-Rx requirement, prescriptions intended for fill at a New York pharmacy must generally be electronic. This creates friction when an out-of-state provider issues a paper or faxed prescription—New York pharmacies may not be able to accept it without one of the statutory exceptions applying.
See how telehealth prescribing laws interact with these rules in our guide to Telehealth Prescribing by State.
How PDMP Systems Affect Interstate Fills
Every U.S. state and territory now operates a Prescription Drug Monitoring Program (PDMP). The NABP's PMP InterConnect system links most state PDMPs, allowing pharmacists and prescribers to check a patient's controlled substance history across state lines [12].
When a patient presents an out-of-state controlled substance prescription, the dispensing pharmacist in most states is required to check their state's PDMP before filling it. Through PMP InterConnect, they can often see the patient's prescription history from the originating state as well.
Two notable exceptions to full interstate data sharing:
- California restricts data sharing to the Veterans Health Administration only.
- Missouri state law prohibits interstate PDMP data sharing entirely [12].
These gaps mean that pharmacists filling out-of-state prescriptions in or from these states may lack complete dispensing history, which can slow down or prevent a fill—particularly for opioids and other high-risk medications.
For a complete breakdown of PDMP requirements, see our PDMP Requirements Guide guide.
Step-by-Step: How to Transfer a Prescription Across State Lines
Whether you're a pharmacist processing a transfer or a clinician advising a relocating patient, here's the process:
For Non-Controlled Medications
- The patient contacts the receiving pharmacy (ideally the same chain as their current pharmacy) and requests a transfer.
- The receiving pharmacist contacts the transferring pharmacy directly.
- Prescription details, remaining refills, and prescriber information are communicated pharmacist-to-pharmacist.
- The transferring pharmacy voids the original prescription. The receiving pharmacy creates a new record.
- The patient presents ID and insurance at the new pharmacy to pick up.
For Schedule III–V Controlled Substances
- Follow the same steps above, but note the one-time transfer limit under 21 CFR 1306.25 unless both pharmacies share a real-time database.
- The transferring pharmacist must write "VOID" on the original (paper) or annotate the electronic record.
- The receiving pharmacist must document the transfer source, including the originating pharmacy's DEA number and prescription number.
- Verify state law permits the transfer—some states impose additional documentation requirements or prohibit certain transfers.
For Schedule II Controlled Substances (Electronic Only)
- The patient requests the transfer. The original e-prescription must be unfilled.
- The transferring pharmacist communicates directly with the receiving pharmacist.
- The prescription must remain electronic and unaltered.
- Both pharmacies must be DEA-registered retail pharmacies using SCRIPT Standard Version 2017071 or later [3].
- Confirm the receiving state permits Schedule II transfers—states like PA and NJ prohibit them.
Insurance and Medicaid: Will Your Plan Cover an Out-of-State Fill?
Regulatory permission to fill is only half the equation. Insurance coverage adds another layer.
| Plan Type | Out-of-State Coverage | Key Considerations |
|---|---|---|
| Commercial PPO/HMO | Usually covered at in-network chain pharmacies | Out-of-network pharmacies may require cash payment and manual reimbursement |
| Medicare Part D | Covered at any network pharmacy nationwide | Some plans offer vacation supply overrides for early refills |
| Medicaid | Generally does not cover out-of-state fills | Patients may need to pay cash or use discount cards; some states have reciprocal agreements for border-area patients |
| Tricare | Covered at network pharmacies nationwide | Military pharmacies may have separate dispensing rules |
For patients on Medicaid who are relocating, the gap between losing coverage in one state and gaining it in another can leave them without pharmacy benefits for weeks. Advising these patients to request a 90-day supply before their move—or to apply for Medicaid in the new state before relocating—can prevent dangerous gaps in therapy.
What About Telehealth Prescriptions Across State Lines?
The intersection of telehealth and interstate prescribing has been in flux since the end of the COVID-19 public health emergency.
The DEA's Ryan Haight Act generally requires an in-person evaluation before prescribing controlled substances. Pandemic-era flexibilities allowing telemedicine prescribing without an in-person visit were extended through late 2025, with the DEA publishing a proposed rule for permanent telemedicine registration that remained unfinalized as of early 2026 [13].
Key points for 2026:
- A telehealth prescriber must hold a license in the state where the patient is physically located at the time of the encounter.
- States like Florida prohibit Schedule II prescribing via telehealth except in limited circumstances [5].
- New York finalized rules in 2025 aligning its controlled substance telemedicine prescribing with federal allowances, generally permitting what the DEA permits [13].
- Some states require an in-person visit within 12 months before or after the initial telehealth-based controlled substance prescription.
For prescriber-specific scope rules, check our PA Prescribing Authority by State guide.
NABP's Interstate Practice Privilege Model: What's Coming
As of mid-2025, the NABP has been developing a pharmacist interstate practice privilege model that would allow pharmacists licensed in one participating state to provide services in other participating states without obtaining a full license in each [14]. This model builds on the existing Electronic Licensure Transfer Program (eLTP) and NABP Verify infrastructure.
The model is still in development with state-by-state legislative adoption required. If enacted broadly, it could simplify the regulatory landscape for pharmacists practicing across state lines—particularly in telepharmacy, central fill, and remote verification settings. However, it addresses pharmacist licensure, not prescription validity, so the state-level restrictions on controlled substance transfers described above would remain unchanged.
References
1. https://www.deadiversion.usdoj.gov/GDP/(DEA-DC-85)(EO-DEA180)_Filling_CS_Rx_from_Out_of_State_Pract_(Final).pdf
2. https://www.ecfr.gov/current/title-21/chapter-II/part-1306/subject-group-ECFRe4ae2bfb4eae102/section-1306.25
3. https://www.dea.gov/stories/2023/2023-09/2023-09-01/revised-regulation-allows-dea-registered-pharmacies-transfer
5. https://www.leg.state.fl.us/statutes/index.cfm?App_mode=Display_Statute&URL=0400-0499/0465/Sections/0465.026.html
6. https://www.mass.gov/circular-letter/circular-letter-dcp-21-10-111-out-of-state-schedule-ii-prescriptions-and-supervised-prescribing-2
7. https://www.law.cornell.edu/regulations/new-jersey/N-J-A-C-13-39-7-8
8. https://www.health.ny.gov/professionals/narcotic/electronic_prescribing/
9. https://www.papharmacists.com/page/FederalLaws
10. https://www.pharmacy.texas.gov/consumer/broch4.asp
11. https://www.azleg.gov/viewdocument/?docName=https://www.azleg.gov/ars/36/02525.htm
12. https://nabp.pharmacy/members/programs-services/pmp-interconnect/
13. https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/
14. https://nabp.pharmacy/news/blog/breaking-down-barriers-in-pharmacist-license-portability/
Frequently Asked Questions
About the Author
Dr. Zade Shammout, PharmD writes about prescription medications, pharmacy laws, and healthcare compliance for prescribers and pharmacists.

